Arcadia Biosciences, Inc. — Director's Dealing 2016

Aug 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-08-04

Reporting Person: Salameh Roger (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-04	Common Stock	M	100	$1.08	Acquired	11515	Direct
2016-08-04	Common Stock	S	100	$2.51	Disposed	11415	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-04	Employee Stock Option (right to buy)	$1.08	M	100	Disposed	2018-06-30	Common Stock (100)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1297	Indirect

Footnotes

F1: The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective June 14, 2016.

F2: The total securities reflects the transfer of all rights and ownership interest in and to 9,006 shares (or 50% of the total beneficially owned) to the Reporting Person's ex-wife effective December 10, 2015, and the acquisition of 750 shares and 1,659 shares on February 1 and August 1, 2016, respectively, through participation in the Issuer's 2015 Employee Stock Purchase Plan.

F3: Represents the acquisition of 667 and 630 shares on February 1 and August 1, 2016, respectively, by the Reporting Person's spouse through her participation in the Issuer's 2015 Employee Stock Purchase Plan, for which the Reporting Person disclaims beneficial ownership.

F4: The option is fully exercisable as of the date hereof.